

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 7.20948374 |
| 2 | DNA deamination (GO:0045006) | 6.68205580 |
| 3 | proline metabolic process (GO:0006560) | 5.84511371 |
| 4 | positive regulation of protein homooligomerization (GO:0032464) | 5.23434618 |
| 5 | transcription from mitochondrial promoter (GO:0006390) | 5.21023401 |
| 6 | replication fork processing (GO:0031297) | 4.99419025 |
| 7 | embryonic process involved in female pregnancy (GO:0060136) | 4.87646466 |
| 8 | cellular response to zinc ion (GO:0071294) | 4.65554883 |
| 9 | oxidative demethylation (GO:0070989) | 4.64070146 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.61230332 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.61230332 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.61230332 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.61230332 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.61230332 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.61230332 |
| 16 | response to peptidoglycan (GO:0032494) | 4.53858109 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.51146375 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.51146375 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33693592 |
| 20 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 4.30427737 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.23846507 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.22729402 |
| 23 | regulation of protein homooligomerization (GO:0032462) | 4.19281184 |
| 24 | detection of bacterium (GO:0016045) | 4.16577072 |
| 25 | regulation of integrin activation (GO:0033623) | 4.16224210 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14964772 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.14964772 |
| 28 | detection of other organism (GO:0098543) | 4.14880170 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.10973346 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 4.04460266 |
| 31 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.95020117 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.93126991 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.92329691 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.83697234 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73687020 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64944541 |
| 37 | mitochondrial DNA metabolic process (GO:0032042) | 3.64191043 |
| 38 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.58613896 |
| 39 | response to type I interferon (GO:0034340) | 3.56777906 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.55245152 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.55245152 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.54948572 |
| 43 | mRNA cleavage (GO:0006379) | 3.54330127 |
| 44 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.53248463 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44650019 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.44091002 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.41197239 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38324670 |
| 49 | cellular extravasation (GO:0045123) | 3.35517958 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31877713 |
| 51 | mitotic G1/S transition checkpoint (GO:0044819) | 3.31601759 |
| 52 | phospholipid scrambling (GO:0017121) | 3.29695551 |
| 53 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.29599945 |
| 54 | positive regulation of lamellipodium assembly (GO:0010592) | 3.28690023 |
| 55 | viral mRNA export from host cell nucleus (GO:0046784) | 3.28529089 |
| 56 | positive regulation of developmental pigmentation (GO:0048087) | 3.28239827 |
| 57 | response to muramyl dipeptide (GO:0032495) | 3.28078552 |
| 58 | respiratory burst (GO:0045730) | 3.26760625 |
| 59 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.24373743 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22457890 |
| 61 | pentose metabolic process (GO:0019321) | 3.21709812 |
| 62 | germinal center formation (GO:0002467) | 3.20370504 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19987471 |
| 64 | B cell mediated immunity (GO:0019724) | 3.19864313 |
| 65 | T cell migration (GO:0072678) | 3.17255471 |
| 66 | neutrophil activation (GO:0042119) | 3.16544996 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 3.16495467 |
| 68 | negative regulation of protein oligomerization (GO:0032460) | 3.15757050 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15289219 |
| 70 | response to host immune response (GO:0052572) | 3.15289219 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.14097477 |
| 72 | G1 DNA damage checkpoint (GO:0044783) | 3.12927527 |
| 73 | positive thymic T cell selection (GO:0045059) | 3.12553088 |
| 74 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.12073701 |
| 75 | positive regulation by host of viral transcription (GO:0043923) | 3.11229021 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.09508194 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08637888 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08503798 |
| 79 | granulocyte activation (GO:0036230) | 3.08393627 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07890266 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07348863 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 3.07309116 |
| 83 | regulation of B cell differentiation (GO:0045577) | 3.06965340 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06572619 |
| 85 | positive regulation of protein oligomerization (GO:0032461) | 3.05693661 |
| 86 | interferon-gamma secretion (GO:0072643) | 3.05011406 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 3.04365055 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.03896985 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 3.03847890 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 3.03794160 |
| 91 | cellular response to ATP (GO:0071318) | 3.02697176 |
| 92 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.01743725 |
| 93 | DNA integration (GO:0015074) | 3.00673586 |
| 94 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.00227858 |
| 95 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.00227858 |
| 96 | detection of biotic stimulus (GO:0009595) | 2.99516160 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96111706 |
| 98 | response to host (GO:0075136) | 2.96111706 |
| 99 | response to host defenses (GO:0052200) | 2.96111706 |
| 100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95486926 |
| 101 | tolerance induction (GO:0002507) | 2.95382428 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.94225018 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.92397551 |
| 104 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.92084318 |
| 105 | B cell receptor signaling pathway (GO:0050853) | 2.90399860 |
| 106 | macrophage activation (GO:0042116) | 2.90255034 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90168419 |
| 108 | thymic T cell selection (GO:0045061) | 2.90143562 |
| 109 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.89992204 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89153495 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89079993 |
| 112 | base-excision repair (GO:0006284) | 2.88989891 |
| 113 | response to interleukin-15 (GO:0070672) | 2.85841913 |
| 114 | T cell selection (GO:0045058) | 2.84836695 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83691108 |
| 116 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83537487 |
| 117 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.83484770 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82945058 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.82358997 |
| 120 | regulation of protein oligomerization (GO:0032459) | 2.81132749 |
| 121 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79538893 |
| 122 | activation of MAPKKK activity (GO:0000185) | 2.79321020 |
| 123 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.78789943 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.78402983 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.77205137 |
| 126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77056505 |
| 127 | sulfur amino acid catabolic process (GO:0000098) | 2.76832109 |
| 128 | negative regulation of stress fiber assembly (GO:0051497) | 2.76258716 |
| 129 | sphingomyelin metabolic process (GO:0006684) | 2.75968671 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.75566108 |
| 131 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.75304156 |
| 132 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.75304156 |
| 133 | termination of RNA polymerase II transcription (GO:0006369) | 2.73966004 |
| 134 | embryonic placenta development (GO:0001892) | 2.73658590 |
| 135 | base-excision repair, AP site formation (GO:0006285) | 2.73185028 |
| 136 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.72804790 |
| 137 | defense response to protozoan (GO:0042832) | 2.72713622 |
| 138 | negative T cell selection (GO:0043383) | 2.72583188 |
| 139 | leukocyte aggregation (GO:0070486) | 2.72487212 |
| 140 | negative regulation of cell cycle arrest (GO:0071157) | 2.72457261 |
| 141 | microglial cell activation (GO:0001774) | 2.72436083 |
| 142 | heme biosynthetic process (GO:0006783) | 2.72395965 |
| 143 | regulation of tolerance induction (GO:0002643) | 2.72369662 |
| 144 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72056481 |
| 145 | regulation of mast cell activation (GO:0033003) | 2.71722769 |
| 146 | cellular response to interleukin-15 (GO:0071350) | 2.71292490 |
| 147 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70713071 |
| 148 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.68757448 |
| 149 | regulation of lamellipodium assembly (GO:0010591) | 2.68754967 |
| 150 | negative regulation of innate immune response (GO:0045824) | 2.68468620 |
| 151 | positive regulation of B cell differentiation (GO:0045579) | 2.68442841 |
| 152 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.68270996 |
| 153 | membrane invagination (GO:0010324) | 2.67804045 |
| 154 | mannose metabolic process (GO:0006013) | 2.67366110 |
| 155 | negative thymic T cell selection (GO:0045060) | 2.67336833 |
| 156 | mitochondrial RNA metabolic process (GO:0000959) | 2.66844443 |
| 157 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66228782 |
| 158 | leukocyte degranulation (GO:0043299) | 2.65079079 |
| 159 | regulation of mitochondrial depolarization (GO:0051900) | 2.64659537 |
| 160 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.60582515 |
| 161 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58994469 |
| 162 | DNA strand elongation (GO:0022616) | 2.58088286 |
| 163 | negative regulation of mRNA processing (GO:0050686) | 2.57611000 |
| 164 | DNA strand renaturation (GO:0000733) | 2.56065287 |
| 165 | positive regulation of lamellipodium organization (GO:1902745) | 2.52665080 |
| 166 | regulation of translational fidelity (GO:0006450) | 2.51075207 |
| 167 | leukocyte cell-cell adhesion (GO:0007159) | 2.50567754 |
| 168 | formation of translation preinitiation complex (GO:0001731) | 2.50144240 |
| 169 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.49471578 |
| 170 | negative regulation of RNA splicing (GO:0033119) | 2.48205221 |
| 171 | response to protozoan (GO:0001562) | 2.47248393 |
| 172 | establishment of apical/basal cell polarity (GO:0035089) | 2.46313194 |
| 173 | negative regulation of viral release from host cell (GO:1902187) | 2.44007114 |
| 174 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43544590 |
| 175 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.43173295 |
| 176 | nuclear envelope reassembly (GO:0031468) | 2.42801038 |
| 177 | mitotic nuclear envelope reassembly (GO:0007084) | 2.42801038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.29674952 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82308243 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.45833191 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.45555370 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41821814 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.39747942 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38962821 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.35680711 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20681454 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20247917 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12576797 |
| 12 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 2.01700518 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99281435 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 1.92280451 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91850803 |
| 16 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89953381 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87425038 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.87199232 |
| 19 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.85784510 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85705984 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83228431 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82236566 |
| 23 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77987590 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77878280 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77332458 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73808553 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73164607 |
| 28 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.71479917 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70145465 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69818755 |
| 31 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.68988432 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68895398 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66153537 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64919005 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.64465285 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63898731 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60784368 |
| 38 | * MAF_26560356_Chip-Seq_TH2_Human | 1.59300200 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57777691 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56681927 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55663772 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.54280449 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52309100 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51845229 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51413914 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50690124 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50238985 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48562979 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48173914 |
| 50 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.47964318 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47913246 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47710236 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47366191 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46761919 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45882071 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.45663408 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43488876 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42252595 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41580545 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40234394 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39202607 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38271768 |
| 63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37776542 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36624536 |
| 65 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34812657 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33254871 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31778360 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31750987 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29627426 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28299952 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28018689 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27773883 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27091412 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27011266 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26875825 |
| 76 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25761206 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24075113 |
| 78 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23360038 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.22814751 |
| 80 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.22164881 |
| 81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22044920 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21926403 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21838228 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21649842 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21314259 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21308454 |
| 87 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20707331 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20352416 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19954490 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19652084 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19547852 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19380470 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19359819 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18608727 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18410068 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17897454 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17834024 |
| 98 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17003284 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16212555 |
| 100 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15938553 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15600262 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15598322 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14709497 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13965926 |
| 105 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13906491 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13511968 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13471223 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13262321 |
| 109 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13133981 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13089481 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13050414 |
| 112 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12766483 |
| 113 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.11907594 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11070153 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09987775 |
| 116 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09848937 |
| 117 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09506872 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08759553 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08241953 |
| 120 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07890786 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07655578 |
| 122 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06993286 |
| 123 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06966872 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06739724 |
| 125 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06391503 |
| 126 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06233213 |
| 127 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05816247 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05339233 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 1.05084090 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04873236 |
| 131 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04726583 |
| 132 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00336992 |
| 133 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99531606 |
| 134 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97656396 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95995597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.51063948 |
| 2 | MP0000685_abnormal_immune_system | 3.38632543 |
| 3 | MP0009278_abnormal_bone_marrow | 3.07493272 |
| 4 | MP0006082_CNS_inflammation | 2.85865917 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.76743473 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.52696385 |
| 7 | MP0005671_abnormal_response_to | 2.51982007 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.38245446 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.38245446 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.33141309 |
| 11 | MP0001873_stomach_inflammation | 2.32252881 |
| 12 | MP0001800_abnormal_humoral_immune | 2.25947552 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.23923470 |
| 14 | MP0002009_preneoplasia | 2.23246489 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.21205460 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.19016698 |
| 17 | MP0005451_abnormal_body_composition | 2.17267926 |
| 18 | MP0009785_altered_susceptibility_to | 2.13790173 |
| 19 | MP0002405_respiratory_system_inflammati | 2.13543436 |
| 20 | MP0005387_immune_system_phenotype | 2.12649602 |
| 21 | MP0001790_abnormal_immune_system | 2.12649602 |
| 22 | MP0009840_abnormal_foam_cell | 2.07055602 |
| 23 | MP0005025_abnormal_response_to | 2.05057324 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.04786960 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.04054084 |
| 26 | MP0002398_abnormal_bone_marrow | 2.02450956 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.01959750 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.00065837 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.99033014 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.92169790 |
| 31 | * MP0002723_abnormal_immune_serum | 1.91622330 |
| 32 | MP0005365_abnormal_bile_salt | 1.90482364 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.88232368 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.87301700 |
| 35 | MP0001819_abnormal_immune_cell | 1.86447724 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.85763927 |
| 37 | MP0008260_abnormal_autophagy | 1.84507591 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.81833058 |
| 39 | MP0005171_absent_coat_pigmentation | 1.76370619 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.74513443 |
| 41 | * MP0000716_abnormal_immune_system | 1.74403206 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.73296011 |
| 43 | MP0003436_decreased_susceptibility_to | 1.72294884 |
| 44 | MP0003866_abnormal_defecation | 1.72244900 |
| 45 | MP0002722_abnormal_immune_system | 1.71700059 |
| 46 | MP0000490_abnormal_crypts_of | 1.69453750 |
| 47 | MP0002419_abnormal_innate_immunity | 1.65125238 |
| 48 | MP0002006_tumorigenesis | 1.58144013 |
| 49 | MP0004381_abnormal_hair_follicle | 1.57545430 |
| 50 | MP0000858_altered_metastatic_potential | 1.56351036 |
| 51 | MP0003724_increased_susceptibility_to | 1.53427652 |
| 52 | * MP0002429_abnormal_blood_cell | 1.52082374 |
| 53 | MP0001853_heart_inflammation | 1.51768401 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.45252268 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.41958608 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.41682878 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.39456554 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.33135147 |
| 59 | MP0003303_peritoneal_inflammation | 1.29363441 |
| 60 | MP0005360_urolithiasis | 1.26566779 |
| 61 | MP0008995_early_reproductive_senescence | 1.25975774 |
| 62 | MP0010094_abnormal_chromosome_stability | 1.25884852 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.24400378 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.22737571 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.20759939 |
| 66 | MP0004947_skin_inflammation | 1.18975206 |
| 67 | MP0000371_diluted_coat_color | 1.18908169 |
| 68 | MP0005310_abnormal_salivary_gland | 1.17659608 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.16055276 |
| 70 | MP0002132_abnormal_respiratory_system | 1.15387287 |
| 71 | MP0004510_myositis | 1.11848251 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.09683329 |
| 73 | MP0008058_abnormal_DNA_repair | 1.08216573 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.07456530 |
| 75 | * MP0008469_abnormal_protein_level | 1.07162683 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.06455739 |
| 77 | MP0000609_abnormal_liver_physiology | 1.05591424 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 1.01706166 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.98069869 |
| 80 | MP0002933_joint_inflammation | 0.94358388 |
| 81 | MP0005166_decreased_susceptibility_to | 0.92236069 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.91280606 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 0.90396051 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.89907293 |
| 85 | MP0001851_eye_inflammation | 0.89262355 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.84100250 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.79265177 |
| 88 | MP0000604_amyloidosis | 0.79232546 |
| 89 | MP0003448_altered_tumor_morphology | 0.79020977 |
| 90 | MP0000343_altered_response_to | 0.78308798 |
| 91 | MP0001764_abnormal_homeostasis | 0.76745116 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.76669046 |
| 93 | MP0003045_fibrosis | 0.75840990 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75573537 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.74782542 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.74209393 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.74162465 |
| 98 | MP0000598_abnormal_liver_morphology | 0.73650989 |
| 99 | MP0009763_increased_sensitivity_to | 0.72436436 |
| 100 | MP0005083_abnormal_biliary_tract | 0.71938981 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.70860657 |
| 102 | MP0003075_altered_response_to | 0.69881659 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.69678422 |
| 104 | MP0005390_skeleton_phenotype | 0.69275909 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.69159872 |
| 106 | MP0003077_abnormal_cell_cycle | 0.68614857 |
| 107 | MP0002075_abnormal_coat/hair_pigmentati | 0.67734082 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67433478 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.67076263 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.66846937 |
| 111 | MP0004883_abnormal_blood_vessel | 0.66155485 |
| 112 | MP0004142_abnormal_muscle_tone | 0.65274506 |
| 113 | MP0009764_decreased_sensitivity_to | 0.65205126 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.65056202 |
| 115 | MP0003705_abnormal_hypodermis_morpholog | 0.64894692 |
| 116 | MP0001663_abnormal_digestive_system | 0.64770072 |
| 117 | * MP0000313_abnormal_cell_death | 0.64418395 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.64247940 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.63946572 |
| 120 | MP0008874_decreased_physiological_sensi | 0.63708222 |
| 121 | MP0003828_pulmonary_edema | 0.63644886 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.63606024 |
| 123 | MP0009931_abnormal_skin_appearance | 0.62831750 |
| 124 | MP0005266_abnormal_metabolism | 0.61871370 |
| 125 | * MP0005164_abnormal_response_to | 0.61281826 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.60974517 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.60964967 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.60392034 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.59141655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.78797598 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.77100086 |
| 3 | Increased IgM level (HP:0003496) | 4.72980389 |
| 4 | Myositis (HP:0100614) | 4.57396610 |
| 5 | Poikiloderma (HP:0001029) | 4.26162459 |
| 6 | Orchitis (HP:0100796) | 4.23933350 |
| 7 | Albinism (HP:0001022) | 3.92071134 |
| 8 | Optic neuritis (HP:0100653) | 3.89878219 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.89878219 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.62642768 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61299134 |
| 12 | Nasal polyposis (HP:0100582) | 3.57892840 |
| 13 | Colitis (HP:0002583) | 3.45819329 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.36604289 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.36071912 |
| 16 | IgG deficiency (HP:0004315) | 3.29132713 |
| 17 | IgM deficiency (HP:0002850) | 3.28782170 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 3.27993697 |
| 19 | Abnormality of T cells (HP:0002843) | 3.26733368 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.26005840 |
| 21 | Vasculitis (HP:0002633) | 3.24903738 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 3.24485893 |
| 23 | IgA deficiency (HP:0002720) | 3.19628359 |
| 24 | Encephalitis (HP:0002383) | 3.17448567 |
| 25 | T lymphocytopenia (HP:0005403) | 3.17411370 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.16571992 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.16571992 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.15569877 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.10061321 |
| 30 | Fatigue (HP:0012378) | 3.07212613 |
| 31 | Annular pancreas (HP:0001734) | 3.05850276 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03718476 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03718476 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03718476 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.99813361 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.99813361 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.99813361 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.96182089 |
| 39 | Cellulitis (HP:0100658) | 2.94316587 |
| 40 | Gingivitis (HP:0000230) | 2.93762499 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93147958 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.91920220 |
| 43 | Abnormal hemoglobin (HP:0011902) | 2.90230773 |
| 44 | Hypochromic anemia (HP:0001931) | 2.88807197 |
| 45 | Rib fusion (HP:0000902) | 2.85668156 |
| 46 | Intestinal fistula (HP:0100819) | 2.84689094 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.83053878 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.82817728 |
| 49 | Increased serum ferritin (HP:0003281) | 2.82585534 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.82474411 |
| 51 | Facial hemangioma (HP:0000329) | 2.79286584 |
| 52 | Recurrent viral infections (HP:0004429) | 2.78905775 |
| 53 | Abnormality of male internal genitalia (HP:0000022) | 2.77742873 |
| 54 | Concave nail (HP:0001598) | 2.77499647 |
| 55 | Chronic otitis media (HP:0000389) | 2.76529083 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.74752103 |
| 57 | Hemoptysis (HP:0002105) | 2.73997748 |
| 58 | Ulnar bowing (HP:0003031) | 2.73669229 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.73552794 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.72800911 |
| 61 | Urticaria (HP:0001025) | 2.71230346 |
| 62 | Rectal fistula (HP:0100590) | 2.70421426 |
| 63 | Rectovaginal fistula (HP:0000143) | 2.70421426 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.69247339 |
| 65 | Vaginal fistula (HP:0004320) | 2.68901583 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.68708058 |
| 67 | Polycythemia (HP:0001901) | 2.66279837 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.65428723 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64078320 |
| 70 | Loss of speech (HP:0002371) | 2.62609855 |
| 71 | Eczematoid dermatitis (HP:0000976) | 2.58069981 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.55787828 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.55289427 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.54972168 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.54130036 |
| 76 | B lymphocytopenia (HP:0010976) | 2.54130036 |
| 77 | Hypokinesia (HP:0002375) | 2.51388404 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.50990507 |
| 79 | Alopecia of scalp (HP:0002293) | 2.49332749 |
| 80 | Cheilitis (HP:0100825) | 2.49332421 |
| 81 | Squamous cell carcinoma (HP:0002860) | 2.49014841 |
| 82 | Tongue fasciculations (HP:0001308) | 2.47338486 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.47139285 |
| 84 | Meningitis (HP:0001287) | 2.45572647 |
| 85 | Granulocytopenia (HP:0001913) | 2.41888823 |
| 86 | Leukocytosis (HP:0001974) | 2.39334453 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38336936 |
| 88 | Premature skin wrinkling (HP:0100678) | 2.36408314 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 2.35895573 |
| 90 | Chest pain (HP:0100749) | 2.35327253 |
| 91 | Anorexia (HP:0002039) | 2.34189441 |
| 92 | Recurrent bacterial skin infections (HP:0005406) | 2.30967614 |
| 93 | Lymphopenia (HP:0001888) | 2.30806195 |
| 94 | Epistaxis (HP:0000421) | 2.30206122 |
| 95 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26944225 |
| 96 | Abnormal number of erythroid precursors (HP:0012131) | 2.25404858 |
| 97 | Malnutrition (HP:0004395) | 2.25244458 |
| 98 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.22652655 |
| 99 | Thyroiditis (HP:0100646) | 2.22228597 |
| 100 | Stomatitis (HP:0010280) | 2.22150648 |
| 101 | Slow saccadic eye movements (HP:0000514) | 2.21553753 |
| 102 | Lymphoma (HP:0002665) | 2.21040595 |
| 103 | Osteomyelitis (HP:0002754) | 2.20104372 |
| 104 | Microcytic anemia (HP:0001935) | 2.18540234 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17805952 |
| 106 | Obstructive lung disease (HP:0006536) | 2.17805952 |
| 107 | Hypertensive crisis (HP:0100735) | 2.17559936 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16829634 |
| 109 | Agammaglobulinemia (HP:0004432) | 2.16651352 |
| 110 | Exertional dyspnea (HP:0002875) | 2.16364887 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15993976 |
| 112 | Acute lymphatic leukemia (HP:0006721) | 2.14086623 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.13343905 |
| 114 | Abnormal platelet volume (HP:0011876) | 2.13229146 |
| 115 | Petechiae (HP:0000967) | 2.11359534 |
| 116 | Hypobetalipoproteinemia (HP:0003563) | 2.11254978 |
| 117 | Recurrent skin infections (HP:0001581) | 2.11003278 |
| 118 | Premature graying of hair (HP:0002216) | 2.09600029 |
| 119 | Verrucae (HP:0200043) | 2.09219639 |
| 120 | Papilloma (HP:0012740) | 2.09219639 |
| 121 | Muscle fiber atrophy (HP:0100295) | 2.08895981 |
| 122 | Joint stiffness (HP:0001387) | 2.07634089 |
| 123 | Muscle fibrillation (HP:0010546) | 2.05584684 |
| 124 | Abnormal platelet function (HP:0011869) | 2.05395843 |
| 125 | Impaired platelet aggregation (HP:0003540) | 2.05395843 |
| 126 | Autoimmune thrombocytopenia (HP:0001973) | 2.04502613 |
| 127 | Keratitis (HP:0000491) | 2.03413135 |
| 128 | Hemorrhage of the eye (HP:0011885) | 2.02974586 |
| 129 | Arterial thrombosis (HP:0004420) | 2.02901944 |
| 130 | Lower limb hyperreflexia (HP:0002395) | 2.02585796 |
| 131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00808997 |
| 132 | Large for gestational age (HP:0001520) | 2.00091708 |
| 133 | Emphysema (HP:0002097) | 2.00001618 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99734277 |
| 135 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99734277 |
| 136 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98950362 |
| 137 | Myocardial infarction (HP:0001658) | 1.98070653 |
| 138 | Bowed forearm bones (HP:0003956) | 1.98016451 |
| 139 | Bowing of the arm (HP:0006488) | 1.98016451 |
| 140 | Increased IgE level (HP:0003212) | 1.97331081 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.97191167 |
| 142 | Anteriorly placed anus (HP:0001545) | 1.96848203 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.96407403 |
| 144 | Purpura (HP:0000979) | 1.94899558 |
| 145 | Restrictive lung disease (HP:0002091) | 1.94640217 |
| 146 | Thrombocytosis (HP:0001894) | 1.94633796 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.94362198 |
| 148 | Sepsis (HP:0100806) | 1.93290348 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92999206 |
| 150 | Eosinophilia (HP:0001880) | 1.92800250 |
| 151 | Amyloidosis (HP:0011034) | 1.92482196 |
| 152 | Systemic lupus erythematosus (HP:0002725) | 1.92095826 |
| 153 | Recurrent pneumonia (HP:0006532) | 1.90896867 |
| 154 | Hypertriglyceridemia (HP:0002155) | 1.88943645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.36454108 |
| 2 | ICK | 4.00618478 |
| 3 | MAP3K6 | 3.99574722 |
| 4 | MAP4K1 | 3.57016460 |
| 5 | MAP3K11 | 3.12926020 |
| 6 | CSK | 2.87214534 |
| 7 | PIM2 | 2.66305752 |
| 8 | PINK1 | 2.57366113 |
| 9 | DDR2 | 2.54238854 |
| 10 | MATK | 2.45207214 |
| 11 | FGR | 2.27133219 |
| 12 | PRKD2 | 2.18331149 |
| 13 | MAP3K3 | 2.04822123 |
| 14 | DAPK1 | 1.98997805 |
| 15 | BLK | 1.96118136 |
| 16 | MARK3 | 1.94695042 |
| 17 | YES1 | 1.75511480 |
| 18 | SMG1 | 1.72582294 |
| 19 | PIM1 | 1.70010476 |
| 20 | DYRK1B | 1.65171809 |
| 21 | TYRO3 | 1.64863925 |
| 22 | TBK1 | 1.57377317 |
| 23 | TXK | 1.51440525 |
| 24 | UHMK1 | 1.46576470 |
| 25 | ZAP70 | 1.46034025 |
| 26 | SIK3 | 1.45595861 |
| 27 | NME2 | 1.41557230 |
| 28 | KIT | 1.38525226 |
| 29 | MAP3K10 | 1.35437457 |
| 30 | GRK6 | 1.33377379 |
| 31 | IKBKE | 1.32827504 |
| 32 | BTK | 1.28768535 |
| 33 | IRAK4 | 1.28631460 |
| 34 | LCK | 1.23580366 |
| 35 | IRAK2 | 1.22433562 |
| 36 | MAP3K1 | 1.22416870 |
| 37 | LYN | 1.22163014 |
| 38 | TYK2 | 1.21361859 |
| 39 | CDK7 | 1.19219375 |
| 40 | ERN1 | 1.17585926 |
| 41 | BMX | 1.17215338 |
| 42 | MAPK11 | 1.13307104 |
| 43 | IKBKB | 1.13161274 |
| 44 | TRPM7 | 1.09680643 |
| 45 | MAP2K2 | 1.09067176 |
| 46 | JAK3 | 1.08828719 |
| 47 | TESK2 | 1.07974358 |
| 48 | CDK6 | 1.07572423 |
| 49 | SYK | 1.02541007 |
| 50 | STK10 | 0.98705641 |
| 51 | CDK12 | 0.97286630 |
| 52 | KDR | 0.95899849 |
| 53 | PDPK1 | 0.95612046 |
| 54 | DYRK3 | 0.95510681 |
| 55 | PTK6 | 0.93361832 |
| 56 | RPS6KA6 | 0.93347692 |
| 57 | MARK2 | 0.92546505 |
| 58 | TNK2 | 0.91137312 |
| 59 | MST1R | 0.90800872 |
| 60 | PDK1 | 0.89676315 |
| 61 | ITK | 0.88892700 |
| 62 | RPS6KC1 | 0.88326456 |
| 63 | RPS6KL1 | 0.88326456 |
| 64 | CSF1R | 0.87621922 |
| 65 | IRAK1 | 0.86838952 |
| 66 | TAOK3 | 0.84285586 |
| 67 | EPHB1 | 0.81467947 |
| 68 | TEC | 0.80191954 |
| 69 | MAP2K6 | 0.76192568 |
| 70 | MAPK4 | 0.75892213 |
| 71 | RIPK4 | 0.73800346 |
| 72 | HIPK2 | 0.73425295 |
| 73 | FGFR4 | 0.72198231 |
| 74 | GSK3A | 0.71968478 |
| 75 | RAF1 | 0.71715412 |
| 76 | FLT3 | 0.70775193 |
| 77 | STK16 | 0.66766118 |
| 78 | EPHA2 | 0.66074401 |
| 79 | STK11 | 0.65012157 |
| 80 | FES | 0.64427663 |
| 81 | MAP2K3 | 0.63876861 |
| 82 | KSR2 | 0.63827855 |
| 83 | CDK19 | 0.63372316 |
| 84 | MAP3K8 | 0.62802368 |
| 85 | MAP3K12 | 0.62073770 |
| 86 | SIK2 | 0.61108879 |
| 87 | MAP3K14 | 0.61107620 |
| 88 | HCK | 0.60913415 |
| 89 | NLK | 0.60800713 |
| 90 | BCKDK | 0.57500360 |
| 91 | JAK1 | 0.56069637 |
| 92 | JAK2 | 0.55445709 |
| 93 | PTK2B | 0.51526030 |
| 94 | PRKCQ | 0.50722182 |
| 95 | LRRK2 | 0.49541330 |
| 96 | MELK | 0.49415685 |
| 97 | RPS6KA2 | 0.49004236 |
| 98 | CDK4 | 0.48967141 |
| 99 | PDGFRA | 0.48750994 |
| 100 | IRAK3 | 0.48454756 |
| 101 | PAK4 | 0.47517796 |
| 102 | PKN2 | 0.47092580 |
| 103 | CHUK | 0.46450924 |
| 104 | CHEK2 | 0.45884886 |
| 105 | EIF2AK1 | 0.44993752 |
| 106 | MAP3K7 | 0.44789715 |
| 107 | ABL1 | 0.43960707 |
| 108 | MAPK3 | 0.43174259 |
| 109 | EGFR | 0.43112461 |
| 110 | EEF2K | 0.42957432 |
| 111 | CDC42BPA | 0.42824332 |
| 112 | PRKAA2 | 0.42556331 |
| 113 | MAPK12 | 0.41708907 |
| 114 | TRIB3 | 0.41293122 |
| 115 | TLK1 | 0.40025130 |
| 116 | MAP3K2 | 0.39923778 |
| 117 | RPS6KA1 | 0.39659661 |
| 118 | CSNK1G1 | 0.39466733 |
| 119 | MAP3K13 | 0.39416065 |
| 120 | TAOK2 | 0.39302289 |
| 121 | MAP3K5 | 0.38969692 |
| 122 | RIPK1 | 0.37801372 |
| 123 | PRKG2 | 0.37600611 |
| 124 | SIK1 | 0.36089703 |
| 125 | TGFBR2 | 0.35976617 |
| 126 | PRKCD | 0.35681566 |
| 127 | CLK1 | 0.34013833 |
| 128 | MAPKAPK2 | 0.33327580 |
| 129 | TNIK | 0.33282630 |
| 130 | CDK9 | 0.29594886 |
| 131 | CSNK2A1 | 0.29396210 |
| 132 | TAOK1 | 0.29274846 |
| 133 | PRPF4B | 0.27418553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.45633625 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 3.57884786 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.48121152 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.39955577 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.17506680 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.19475302 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.13573206 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.09742168 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97094893 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89373572 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86105460 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85747560 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84585980 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77708023 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69206226 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.64244813 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.63982160 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59314582 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55493136 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.52253020 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.51813359 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51309870 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.46887295 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43869305 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41852923 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39460585 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39284534 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38906725 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.38512658 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.32821768 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31137115 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29965137 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27144801 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25480768 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.23246197 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22020046 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21586633 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20104670 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18848605 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18358588 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17282163 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16297556 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15290402 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14778998 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14424422 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13046687 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.12791985 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11548480 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11541223 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11021332 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.09600476 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06115459 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06051096 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04115369 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.02384999 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.01151314 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01078530 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98980715 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97067895 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.93331367 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91814467 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89783551 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89325166 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88811856 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88612418 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87163736 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87080367 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86102456 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85547629 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83650684 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82253889 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.82066385 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81979106 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80755205 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.80224852 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79556797 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79509390 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79394034 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76971107 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75887059 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75462446 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.70860762 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70416371 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69303716 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.68408139 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67795582 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66265304 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.66128314 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66016562 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63206326 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63122145 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62757606 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62448017 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62429170 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61198495 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60508013 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60157720 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59988205 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59986497 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59832415 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59015469 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58625377 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58611854 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58067446 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.57195702 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.56721912 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56180832 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55514280 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55415896 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52443954 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52055091 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.51613310 |
| 113 | RNA transport_Homo sapiens_hsa03013 | 0.51032164 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50315770 |
| 115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49460396 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49123748 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.47551826 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45599931 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.45190249 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44547710 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43877921 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43058721 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42658170 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.41689086 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40201887 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38767330 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38373200 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38027173 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36822625 |
| 130 | Cell cycle_Homo sapiens_hsa04110 | 0.36639104 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36360473 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35278027 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34868399 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.34524210 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.34092084 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33420993 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32568111 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31700868 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.31401860 |
| 140 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30193464 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28699601 |
| 142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28573863 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28515428 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27838028 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.27733245 |
| 146 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27016804 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25891492 |
| 148 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24669884 |

